Tulavi Therapeutics, Inc.
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Tulavi Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2021).
SEC Form D · Dec 2021
The industry group it chose in its notices: Biotechnology.
SEC Form D · Dec 2021
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Tulavi Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Corinne Bright | Executive officer | Dec 2021 |
| Farhad Khosravi | Executive officer | Dec 2018 |
| Amar Sawhney | Director | Dec 2021 |
| Corinne Bright | Director | Dec 2021 |
| Farhad Khosravi | Director | Dec 2021 |
| Greg Casciaro | Director | Dec 2021 |
| Henry Chen | Director | Dec 2021 |
| Steve Willamson | Director | Dec 2021 |
| Tara Butler | Director | Dec 2021 |
| Amar Sawney | Director | May 2020 |